Uncover key drivers, emerging technologies, and competitive movements shaping the intravenous (iv) compounding robots market from 2026–2035 with trusted insights from The Business Research Company

What was the valuation of the Veterinary Pharmaceuticals Market in 2026, and what figure is it projected to hit by 2030?

The veterinary pharmaceuticals market size has experienced strong growth in recent years. It is anticipated to increase from $34.92 billion in 2025 to $37.01 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.0%. This historical expansion can be attributed to the increasing prevalence of animal diseases, rising livestock population, growth in companion animals, government regulations supporting animal health, and advancements in veterinary research.

The veterinary pharmaceuticals market is projected for significant expansion in the coming years, with its size anticipated to reach $46.88 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.1%. This growth during the forecast period is primarily driven by factors such as advancements in biopharmaceutical technologies, increased research and development in animal drugs, the integration of precision medicine for animals, the expansion of preventive veterinary healthcare, and growing investments in companion animal pharmaceuticals. Key trends expected in the same period encompass the creation of new veterinary medications, the expansion of companion animal healthcare services, an increase in the application of combination therapies, the broadening of oral and topical drug formulations, and a focus on swift metabolism and high bioavailability.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3809&type=smp

Which Drivers Are Affecting Market Participation In The Veterinary Pharmaceuticals Market?

A projected increase in pet ownership is set to propel the expansion of the veterinary pharmaceuticals market. Pet ownership involves the legal and ethical obligation of individuals or households to ensure the care, maintenance, and welfare of domesticated animals, commonly referred to as pets. The rise in pet ownership stems from people actively seeking companionship and emotional comfort. This escalating trend in pet ownership generates a heightened demand for veterinary care, which subsequently stimulates the advancement of veterinary pharmaceuticals. This occurs by broadening the market for medications, vaccines, and preventive treatments crucial for sustaining the health and well-being of a larger and more varied group of companion animals. For instance, in April 2025, the Canadian Animal Health Institute, a Canada-based trade association, reported that in 2024, Canada housed an estimated 7.2 million dogs and 8.2 million cats, indicating pets are an indispensable part of over half of Canadian households. Thus, the increasing pet ownership is a significant driver for the growth of the veterinary pharmaceuticals market.

What Segment Classifications Make Up The Veterinary Pharmaceuticals Market?

The veterinary pharmaceuticals market covered in this report is segmented –

1) By Type: Veterinary Vaccines, Veterinary Antibiotics, Veterinary Parasiticides, Other Types

2) By Type Of Animal: Livestock, Companion Animals

3) By Type Of Vaccine: Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines, Other Type Of Vaccines

4) By Route Of Administration: Oral, Parenteral, Topical, Other Routes Of Administrations

5) By End User: Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores

Subsegments:

1) By Veterinary Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, DNA Vaccines, Subunit Vaccines

2) By Veterinary Antibiotics: Penicillins, Cephalosporins, Tetracyclines, Fluoroquinolones, Macrolides

3) By Veterinary Parasiticides: Endoparasiticides, Ectoparasiticides, Endectocides, Antiprotozoals

4) By Other Types: Anti-Inflammatory Drugs, Analgesics, Hormonal Medications, Antifungals

Which Competitive Trends Are Impacting The Structure Of The Veterinary Pharmaceuticals Market?

Major companies operating within the veterinary pharmaceuticals market are actively developing novel products, such as molidustat oral suspensions, to attract a wider customer base, increase sales, and boost overall revenue. Molidustat oral suspension specifically refers to a pharmaceutical agent utilized for managing nonregenerative anemia that is linked with chronic kidney disease (CKD) in cats. For example, in September 2023, Elanco Animal Health Incorporated, a pharmaceutical company based in the US, introduced Varenzin-CA1 (molidustat oral suspension). This product stands as the inaugural and sole medication for addressing non-regenerative anemia in cats afflicted with chronic kidney disease (CKD) and garnered provisional approval from the U.S. Food and Drug Administration (FDA). Varenzin-CA1 boasts the distinctive characteristic of being an innovative, needle-free oral suspension intended for cats, allowing for convenient administration at home without the need for in-clinic injections. Moreover, this medication is the first for felines to achieve expanded conditional approval, a regulatory route that encourages the creation of new therapeutic options and broadens treatment choices for animals with rare, serious, or life-threatening conditions, or those for which no effective treatments currently exist.

Which Leading Companies Dominate The Veterinary Pharmaceuticals Market Share?

Major companies operating in the veterinary pharmaceuticals market are Zoetis Inc, Merck & Co. Inc, Boehringer Ingelheim International Gmb, Elanco Animal Health Incorporated, Ceva Sante Animale, Virbac SA, Dechra Pharmaceuticals PLC, Vetoquinol S.A., Phibro Animal Health Corporation, Kyoritsu Seiyaku Corporation, Hebei Chengshengtang Animal Pharmaceutical, Shijiazhuang Fengqiang Animal Pharmaceutical Co .Ltd, Vvaan Lifesciences Private Limited, Century Pharmaceuticals Limited, Cargill India Pvt. Ltd., Jurox Pty Ltd, Bayer, Veteq, Nimrod Veterinary Products Ltd., Bimeda, Orion Animal Health, Petmedix, Eco Animal Health, Teknofarma, Farmavet, Candioli Pharma, Suanfarma, Marino Ibericamed, MPA veterinary, Swetrade Pharmaceuticals AB, Animalcare, VET-AGRO Sp. z o. o, CANPOLAND SA, Cymedica, VIC Group, NITA-FARM, Apicenna LLC, Delos Medica, Provet Group, Bioveta AS, Veterinarski Zavod Subotica, PharmaGal s.r.o., Trifecta Pharmaceuticals USA LLC., Alberta Veterinary Laboratories Ltd., Veterinary Purchasing Co. Ltd, UCBVET, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, Lemavet, Primo Veterinary Medicines Trading LLC., AL Kubara Veterinary Medicines Trading LLC., Eurovets Veterinary Suppliers, Saudi Pharmaceutical Industries, DBK Pharma S.A.E., Dawa Limited, Neimeth International Pharmaceuticals, Osy-Adamu Pharmaceutical Co., Global Vet (U) Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-global-market-report

How Does The Veterinary Pharmaceuticals Market Perform Across Major Global Regions?

North America was the largest region in the veterinary pharmaceuticals market in 2025. Asia-Pacific was the second-largest region in the global veterinary pharmaceuticals market report. The regions covered in the veterinary pharmaceuticals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Veterinary Pharmaceuticals Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3809&type=smp

Browse Through More Reports Similar to the Global Veterinary Pharmaceuticals Market 2026, By The Business Research Company

Veterinary Pharmaceuticals Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-global-market-report

Veterinary Medicine Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-medicine-global-market-report

Companion Animal Pharmaceuticals Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/companion-animal-pharmaceuticals-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company